April 6, 2009 - Evalve Inc. announced today the first enrollment in the ACCESS-Europe study, a post-market observational study of the MitraClip therapy in Europe.
The MitraClip system is the first commercially available treatment option for nonsurgical mitral valve repair for patients suffering from the effects of functional and degenerative mitral regurgitation (MR).
